πŸ‡ΊπŸ‡Έ FDA

Intelligence Platform

Patents

Browse 991 pharma-relevant patents (US and EP, A61K/A61P) linked to tracked companies. Patent cliff and LOE intelligence for BD teams.

29,054 patents indexed
patent

US 7973162

Modulators of muscarinic receptors

Vertex Pharmaceuticals Incorporated Β· Granted Tue Jul 05 2011 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jun 30 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7972813

Tetrodotoxin-resistant sodium channel alpha subunit

Vertex Pharmaceuticals Incorporated Β· Granted Tue Jul 05 2011 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jun 30 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7968545

Compositions useful as inhibitors of voltage-gated ion channels

Vertex Pharmaceuticals Incorporated Β· Granted Tue Jun 28 2011 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jun 23 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7968716

Caspase inhibitors and uses thereof

Vertex Pharmaceuticals Incorporated Β· Granted Tue Jun 28 2011 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jun 23 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7964624

Inhibitors of serine proteases

Vertex Pharmaceuticals Incorporated Β· Granted Tue Jun 21 2011 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jun 16 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7960415

Caspase inhibitors and uses thereof

Vertex Pharmaceuticals Incorporated Β· Granted Tue Jun 14 2011 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jun 09 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7960398

Regulation of TNF-alpha

Vertex Pharmaceuticals Incorporated Β· Granted Tue Jun 14 2011 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jun 09 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7956052

Modulators of ATP-binding cassette transporters

Vertex Pharmaceuticals Incorporated Β· Granted Tue Jun 07 2011 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jun 02 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7951820

Triazole compounds useful as protein kinase inhibitors

Vertex Pharmaceuticals Incorporated Β· Granted Tue May 31 2011 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon May 26 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7951809

Inhibitors of p38

Vertex Pharmaceuticals Incorporated Β· Granted Tue May 31 2011 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon May 26 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7943593

Compositions comprising inhibitors of IMPDH enzyme

Vertex Pharmaceuticals Incorporated Β· Granted Tue May 17 2011 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon May 12 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7928107

Quinazolines useful as modulators of ion channels

Vertex Pharmaceuticals Incorporated Β· Granted Tue Apr 19 2011 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Apr 14 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7919520

Inhibitors of tace

Vertex Pharmaceuticals Incorporated Β· Granted Tue Apr 05 2011 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Mar 31 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7919523

Inhibitors of aspartyl protease

Vertex Pharmaceuticals Incorporated Β· Granted Tue Apr 05 2011 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Mar 31 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7919513

Inhibitors of p38

Vertex Pharmaceuticals Incorporated Β· Granted Tue Apr 05 2011 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Mar 31 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7915385

Sodium channel protein type III Ξ±-subunit splice variant

Vertex Pharmaceuticals Incorporated Β· Granted Tue Mar 29 2011 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Mar 24 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7915305

Thiophene-carboxamides useful as inhibitors of protein kinases

Vertex Pharmaceuticals Incorporated Β· Granted Tue Mar 29 2011 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Mar 24 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7906650

Caspase inhibitors and uses thereof

Vertex Pharmaceuticals Incorporated Β· Granted Tue Mar 15 2011 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Mar 10 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7906550

Inhibitors of serine proteases, particularly HCV NS3-NS4A protease

Vertex Pharmaceuticals Incorporated Β· Granted Tue Mar 15 2011 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Mar 10 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7902239

Diaminotriazoles useful as inhibitors of protein kinases

Vertex Pharmaceuticals Incorporated Β· Granted Tue Mar 08 2011 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Mar 03 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7888384

Heterocyclic derivatives for modulation of calcium channels

Vertex Pharmaceuticals Incorporated Β· Granted Tue Feb 15 2011 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Feb 10 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7884199

HCV NS3-NS4 protease resistance mutants

Vertex Pharmaceuticals Incorporated Β· Granted Tue Feb 08 2011 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Feb 03 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7883881

Inhibitors of GSK-3 and crystal structures of GSK-3Ξ² protein and protein complexes

Vertex Pharmaceuticals Incorporated Β· Granted Tue Feb 08 2011 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Feb 03 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7879834

Spiroindoline modulators of muscarinic receptors

Vertex Pharmaceuticals Incorporated Β· Granted Tue Feb 01 2011 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jan 27 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

granted